Katie Cunningham, Growth Marketing Manager, Author at EverGlade - Page 3 of 5

Katie Cunningham, Growth Marketing Manager

Katie Cunningham, Growth Marketing Manager
DARPA’s Perrseus Program: Manufacturable µUHV for Quantum & Atomic Sensors

DARPA’s Perrseus Program: Manufacturable µUHV for Quantum & Atomic Sensors

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

The Defense Advanced Research Projects Agency (DARPA) Perrseus program is now live with a formal solicitation, moving from concept to concrete timelines and technical expectations. The goal hasn’t changed: build manufacturable, microscale ultra‑high‑vacuum (µUHV) packages that can support next‑generation quantum, MEMS, and photonics‑based sensors without relying on room‑sized vacuum systems. With the solicitation out, teams […]

DARPA’s Perrseus Program: Manufacturable µUHV for Quantum & Atomic Sensors Read More »

New DARPA RFI: Multiscale Reasoning Across Human Physiology

Leave a Comment / All Posts, DARPA, Life Sciences / By

The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released RFI DARPA‑SN‑26‑100 on “Multiscale Reasoning for Human Physiology.” The agency is seeking input from organizations that can connect human biology from molecules to clinical outcomes in support of military medicine. The focus is on prediction, diagnosis, intervention, and recovery in

New DARPA RFI: Multiscale Reasoning Across Human Physiology Read More »

DTRA Topic Call 7: Advanced Bioaerosol Triggers and Engineered Genome Detection

Leave a Comment / All Posts, Defense, DTRA, Emerging Technologies / By

The Defense Threat Reduction Agency (DTRA), under the Department of Defense, has updated its FY2022–2026 Chemical / Biological Technologies Broad Agency Announcement (BAA HDTRA122S0002) with Topic Call 7, adding two new applied research topics in biological threat detection. The BAA is an open, five-year contracting vehicle focused on Technology Readiness Level (TRL) 3–6 technologies, meaning

DTRA Topic Call 7: Advanced Bioaerosol Triggers and Engineered Genome Detection Read More »

BARDA RRPV RFI Seeks Partners for BSL4 Studies and Support Services 

Leave a Comment / All Posts, BARDA, Life Sciences / By

Overview of the Opportunity The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a new Request for Information (RFI) titled “Biosafety Level 4 Preclinical and Nonclinical Support for Medical Countermeasure Development (BSL4)”. Issued July 9, 2026, the RFI is a market research exercise to map out who can deliver preclinical and nonclinical

BARDA RRPV RFI Seeks Partners for BSL4 Studies and Support Services  Read More »

NIAID Renews IMPAc‑TB to Accelerate Tuberculosis Vaccine Development 

Leave a Comment / All Posts, Life Sciences, NIAID / By

Overview of the Opportunity The National Institute of Allergy and Infectious Diseases (NIAID), through the National Institutes of Health (NIH), has issued RFP No. BAA-75N93026R00008 for the Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc‑TB), a five‑year contract program that renews the effort to accelerate TB vaccine development. The goal is to define tissue‑specific and

NIAID Renews IMPAc‑TB to Accelerate Tuberculosis Vaccine Development  Read More »

DOE Opens $150M Funding Opportunity for Improved Oil & Gas Recovery and Produced Water Management Technologies

Leave a Comment / All Posts, DOE, Energy / By

The U.S. Department of Energy (DOE), through its Hydrocarbons and Geothermal Energy Office, has released a new Notice of Funding Opportunity (NOFO) for R&D, field deployment, and validation projects focused on improving recovery from unconventional oil and natural gas reservoirs and advancing produced water treatment technologies. Under DE-FOA-0003627, DOE expects to make up to $150

DOE Opens $150M Funding Opportunity for Improved Oil & Gas Recovery and Produced Water Management Technologies Read More »

Building the $20M Quantum Factory: What NIST’s New Manufacturing Center Means for Innovators 

Leave a Comment / All Posts, Emerging Technologies, Industry, Industry News / By

The federal government is no longer treating quantum as a distant research project. It is building out the industrial base needed to manufacture quantum systems at scale.  On June 28, 2026, the National Institute of Standards and Technology (NIST) announced an agreement with SRI International to establish the Quantum Manufacturing Engineering Center (QMEC). The center is focused on accelerating the

Building the $20M Quantum Factory: What NIST’s New Manufacturing Center Means for Innovators  Read More »

BARDA’s RFI Explores Repurposing Autoinjector Equipment for New Drug Delivery Devices 

Leave a Comment / All Posts, BARDA, Life Sciences / By

Download the Solicitation Overview of the RFI The Biomedical Advanced Research and Development Authority (BARDA) is looking at a specific problem: how to repurpose specialized equipment originally designed to manufacture an emergency autoinjector platform into a broader drug delivery solution. Through the Rapid Response Partnership Vehicle (RRPV), BARDA released a new Request for Information (RFI), “Repurposing Equipment

BARDA’s RFI Explores Repurposing Autoinjector Equipment for New Drug Delivery Devices  Read More »

BARDA Issues RFI on Adjuvanted Egg-Based Influenza Vaccine for Pandemic Preparedness 

Leave a Comment / All Posts, BARDA, Life Sciences / By

Download the Solicitation Overview of the RFI The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a Request for Information (RFI) titled “Advanced Clinical Development and Licensure of an Adjuvanted Egg-based Influenza Vaccine.” Through this market research effort, BARDA is seeking feedback from industry, academia, and other stakeholders to

BARDA Issues RFI on Adjuvanted Egg-Based Influenza Vaccine for Pandemic Preparedness  Read More »

The Escalating Bundibugyo Ebola Outbreak and the $1.4 Billion Push for Biodefense Funding

Leave a Comment / All Posts, Industry News, Life Sciences / By

Since early May, a severe outbreak of the Bundibugyo strain of the Ebola virus (a type of filovirus) has spread rapidly through the Democratic Republic of the Congo and neighboring Uganda. With over 1,000 confirmed infections and more than 290 fatalities already recorded across multiple nations, the second largest Ebola outbreak on record crossed a

The Escalating Bundibugyo Ebola Outbreak and the $1.4 Billion Push for Biodefense Funding Read More »

DOE Sets 2028 Deadline for Fault-Tolerance Quantum Computing Under New Genesis Mission

Leave a Comment / All Posts, DOE, Emerging Technologies, Industry News / By

On June 23, 2026, the Department of Energy (DOE) launched the Quantum Genesis initiative. The goal is both specific and aggressive. The agency plans to develop and deploy the world’s first scientifically relevant, fault-tolerant quantum computer by 2028. This effort is a core component of the broader Genesis Mission, and it signals a major shift

DOE Sets 2028 Deadline for Fault-Tolerance Quantum Computing Under New Genesis Mission Read More »

The End of Mega Labs? What the Proposed NIH Grant Cap Means for Universities

Leave a Comment / All Posts, Industry News, Life Sciences / By

For decades, the biomedical research landscape has been dominated by a relatively small number of highly funded, high-profile laboratories. It is a system that tends to reward past success with future funding. But a newly proposed policy from the National Institutes of Health (NIH) could fundamentally reshape how federal research dollars flow through the U.S.

The End of Mega Labs? What the Proposed NIH Grant Cap Means for Universities Read More »

Scroll to Top